FDA Approves Epidiolex: First Therapeutic Drug Made From Plant-Derived CBD
Co-Author: Josh Zetlin This week the U.S. Food and Drug Administration (FDA) approved Epidiolex as a treatment for seizures associated with two rare and severe forms of epilepsy: Lennox-Gastaut syndrome and Dravet syndrome. Epidiolex, developed by GW Pharmaceuticals plc (Nasdaq: GWPH), a UK-based pharmaceutical company with U.S. operations, is the first FDA-approved drug made from a purified substance derived from
Rogoway Law Group
June 28, 2018